Last update Sept. 17, 2022

Ελλαγικό οξύ

Very Low Risk

Safe. Compatible. Minimal risk for breastfeeding and infant.

It is a polyphenol present in some plants mostly fruits like chestnuts, walnuts, blueberries, raspberries, blackberries, strawberries, cherries, grapes, peaches, and pomegranates. Anti-oxidant  properties are recognized. It has been used as photo protective agent in dermatological compounds. 

Since the last update we have not found published data on its excretion in breastmilk.

It is a non-toxic product, found in many foods, so it is not expected to cause problems during lactation.

Its efficacy in treating or preventing cancer and chronic inflammatory diseases is under investigation (Rios 2018, Jaman 2018, Derosa 2016). Large, well-designed studies are needed to provide evidence for the efficacy of antioxidant supplementation in these conditions. (Block 2007)

Alternatives

We do not have alternatives for Ελλαγικό οξύ since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Ελλαγικό οξύ is Ellagic Acid in Greek.

Is written in other languages:

Ελλαγικό οξύ is also known as

Pharmacokinetics

Variable Value Unit
Molecular weight 302 daltons
pKa 5.54 -
Tmax 1 hours
4 hours

References

  1. Jaman MS, Sayeed MA. Ellagic acid, sulforaphane, and ursolic acid in the prevention and therapy of breast cancer: current evidence and future perspectives. Breast Cancer. 2018 Sep;25(5):517-528. Abstract
  2. Ríos JL, Giner RM, Marín M, Recio MC. A Pharmacological Update of Ellagic Acid. Planta Med. 2018 Oct;84(15):1068-1093. Abstract
  3. Derosa G, Maffioli P, Sahebkar A. Ellagic Acid and Its Role in Chronic Diseases. Adv Exp Med Biol. 2016;928:473-479. Review. Abstract
  4. Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev. 2007 Aug;33(5):407-18. Epub 2007 Mar 23. Review. Abstract

Total visits

115

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM